PF-03716539
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-03716539, covering 2009-06-02 to 2009-06-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects [Phase 1]